EUVIMEDEUVIMED entdecken
Open Access

Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes

Andrea Trevisan iD, João M G Candeias, Patrícia Thomann, Luisa L Villa, Eduardo L Franco iD, Helen Trottier

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Andrea Trevisan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Papillomavirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Little is known about the protection conferred by antibodies from natural human papillomavirus (HPV) infection. Our objective was to evaluate the association between HPV16 seroreactivity and HPV16 redetection, newly detected HPV infections, and loss of HPV DNA detection during follow‐up. We analyzed data from 2462 unvaccinated Brazilian women. HPV16 IgG and neutralizing antibodies at baseline were assessed by enzyme‐linked immunosorbent assay ( n = 1975) and by the pseudovirus‐based papillomavirus neutralization assay ( n = 487). HPV detection, genotyping, and viral load were assessed by PCR‐based methods. The associations were analyzed by Cox proportional hazards models. We observed a positive association between HPV16 IgG seroreactivity and redetection of HPV16 infections. Age‐adjusted hazard ratios (HR) with 95% confidence intervals (CI) ranged from 2.45 (1.04–5.74) to 5.10 (1.37–19.00). Positive associations were also observed between HPV16 IgG antibodies and (1) newly detected HPV infections by genotypes unrelated to HPV16 (age‐adjusted HR [95% CI] = 1.32 [1.08–1.2]) and (2) loss of detection of HPV infections by genotypes unrelated to HPV16 (age‐adjusted HR [95% CI] = 1.24 [1.03–1.50]). Naturally developed HPV16 antibodies do not prevent recurrent HPV infections. Overall HPV16 IgG and neutralizing antibodies seem to be serological markers for latent or past infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHumansFemaleHuman papillomavirus 16Antibodies, ViralImmunoglobulin GAntibodies, Neutralizing

Stichwörter der Autor:innen

HPV16IgGneutralizing antibodiespersistenceredetectionreinfection

Substanzen

Antibodies, ViralImmunoglobulin GAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, Quebec, Canada.
  • Sainte-Justine Hospital Research Center, Université de Montréal, Montreal, Quebec, Canada.
  • Department of Microbiology and Immunology, Institute of Biosciences, Universidade Estadual Paulista, Botucatu, Brazil.
  • Ludwig Institute for Cancer Research, Sao Paulo, Brazil.
  • Instituto do Cancer do Estado de São Paulo, Universidade de São Paulo, Sao Paulo, Brazil.
  • Department of Radiology and Oncology, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil.

ORCID-Profile: Andrea Trevisan, Eduardo L Franco

Förderung

  • NCI NIH HHS
  • CIHR

Zitieren

APA

Trevisan, A., Candeias, J. M. G., Thomann, P., Villa, L. L., Franco, E. L., & Trottier, H. (2024). Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes. Journal of Medical Virology. https://doi.org/10.1002/jmv.29608

Vancouver

Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H. Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes. Journal of Medical Virology. 2024. doi:10.1002/jmv.29608

BibTeX
@article{Trevisan2024,
  author = {Trevisan, Andrea and Candeias, João M G and Thomann, Patrícia and Villa, Luisa L and Franco, Eduardo L and Trottier, Helen},
  title = {Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29608}
}
Kostenlos starten →